FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808066402> ?p ?o ?g. }

• W2808066402 endingPage "311" @default.
• W2808066402 startingPage "304" @default.
• W2808066402 abstract "Background and aims Plasma apolipoprotein M (APOM) is bound to HDL-particles and has anti-atherogenic effects. The present study explored whether plasma APOM is reduced in patients with chronic kidney disease (CKD), and associated with cardiovascular disease (CVD). In addition, we tested the hypothesis that the excretion of APOM into the urine is increased in patients with kidney disease. Methods Plasma samples were collected from a cohort of patients with CKD stages 1 to 5D (N = 409) and controls (N = 35). Urine was collected from 47 subjects. Plasma APOM was measured with sandwich ELISA and urine APOM with competitive ELISA. Results Plasma APOM levels were reduced in patients with CKD stages 3-5D as compared to patients with CKD stages 1 + 2 and controls (p < 0.01). CKD patients with known CVD displayed even further reduction in plasma APOM levels than CKD patients without known CVD (p < 0.001). Fast-phase liquid chromatography showed that plasma APOM was primarily associated with HDL-cholesterol (HDL-C) across CKD stages. Accordingly, when plasma APOM values were corrected for HDL-C, a significant difference only persisted between patients with CKD stage 3 and stages 1 + 2 (p < 0.05), and the difference between CKD patients with and without known CVD disappeared. Urine APOM/creatinine ratio was not significantly increased in patients with kidney disease. Conclusions The results show that the difference in plasma APOM levels observed between patients with mild and advanced CKD may mainly be due to differences in plasma HDL-C. Whether APOM plays a role in human uremic atherogenesis warrants further experimental studies." @default.
• W2808066402 created "2018-06-21" @default.
• W2808066402 creator A5016974789 @default.
• W2808066402 creator A5017691479 @default.
• W2808066402 creator A5019890468 @default.
• W2808066402 creator A5038472200 @default.
• W2808066402 creator A5045391693 @default.
• W2808066402 creator A5050961854 @default.
• W2808066402 creator A5068524218 @default.
• W2808066402 creator A5076173915 @default.
• W2808066402 creator A5081407287 @default.
• W2808066402 date "2018-08-01" @default.
• W2808066402 modified "2023-10-16" @default.
• W2808066402 title "Apolipoprotein M in patients with chronic kidney disease" @default.
• W2808066402 cites W1571704165 @default.
• W2808066402 cites W1968045991 @default.
• W2808066402 cites W1968364422 @default.
• W2808066402 cites W1976206401 @default.
• W2808066402 cites W1979138327 @default.
• W2808066402 cites W1979799609 @default.
• W2808066402 cites W1980988687 @default.
• W2808066402 cites W1982007286 @default.
• W2808066402 cites W1990656857 @default.
• W2808066402 cites W1992495544 @default.
• W2808066402 cites W2015881389 @default.
• W2808066402 cites W2019825424 @default.
• W2808066402 cites W2020531284 @default.
• W2808066402 cites W2032392307 @default.
• W2808066402 cites W2033054571 @default.
• W2808066402 cites W2036060505 @default.
• W2808066402 cites W2038607614 @default.
• W2808066402 cites W2049869221 @default.
• W2808066402 cites W2053942717 @default.
• W2808066402 cites W2065846924 @default.
• W2808066402 cites W2070382695 @default.
• W2808066402 cites W2072787615 @default.
• W2808066402 cites W2073752843 @default.
• W2808066402 cites W2079169688 @default.
• W2808066402 cites W2087773817 @default.
• W2808066402 cites W2089481024 @default.
• W2808066402 cites W2095732090 @default.
• W2808066402 cites W2104130993 @default.
• W2808066402 cites W2111663222 @default.
• W2808066402 cites W2112816524 @default.
• W2808066402 cites W2130552295 @default.
• W2808066402 cites W2137735884 @default.
• W2808066402 cites W2145632027 @default.
• W2808066402 cites W2147589893 @default.
• W2808066402 cites W2149030597 @default.
• W2808066402 cites W2150211631 @default.
• W2808066402 cites W2154975997 @default.
• W2808066402 cites W2155965977 @default.
• W2808066402 cites W2160219552 @default.
• W2808066402 cites W2166180650 @default.
• W2808066402 cites W2167988025 @default.
• W2808066402 cites W2169879227 @default.
• W2808066402 cites W2193196811 @default.
• W2808066402 cites W2470481127 @default.
• W2808066402 cites W2613325828 @default.
• W2808066402 cites W2159003009 @default.
• W2808066402 doi "https://doi.org/10.1016/j.atherosclerosis.2018.06.815" @default.
• W2808066402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29980057" @default.
• W2808066402 hasPublicationYear "2018" @default.
• W2808066402 type Work @default.
• W2808066402 sameAs 2808066402 @default.
• W2808066402 citedByCount "15" @default.
• W2808066402 countsByYear W28080664022018 @default.
• W2808066402 countsByYear W28080664022019 @default.
• W2808066402 countsByYear W28080664022020 @default.
• W2808066402 countsByYear W28080664022021 @default.
• W2808066402 countsByYear W28080664022022 @default.
• W2808066402 countsByYear W28080664022023 @default.
• W2808066402 crossrefType "journal-article" @default.
• W2808066402 hasAuthorship W2808066402A5016974789 @default.
• W2808066402 hasAuthorship W2808066402A5017691479 @default.
• W2808066402 hasAuthorship W2808066402A5019890468 @default.
• W2808066402 hasAuthorship W2808066402A5038472200 @default.
• W2808066402 hasAuthorship W2808066402A5045391693 @default.
• W2808066402 hasAuthorship W2808066402A5050961854 @default.
• W2808066402 hasAuthorship W2808066402A5068524218 @default.
• W2808066402 hasAuthorship W2808066402A5076173915 @default.
• W2808066402 hasAuthorship W2808066402A5081407287 @default.
• W2808066402 hasConcept C10146269 @default.
• W2808066402 hasConcept C126322002 @default.
• W2808066402 hasConcept C134018914 @default.
• W2808066402 hasConcept C2778163477 @default.
• W2808066402 hasConcept C2778653478 @default.
• W2808066402 hasConcept C2780026642 @default.
• W2808066402 hasConcept C2780306776 @default.
• W2808066402 hasConcept C62746215 @default.
• W2808066402 hasConcept C71924100 @default.
• W2808066402 hasConcept C90924648 @default.
• W2808066402 hasConceptScore W2808066402C10146269 @default.
• W2808066402 hasConceptScore W2808066402C126322002 @default.
• W2808066402 hasConceptScore W2808066402C134018914 @default.
• W2808066402 hasConceptScore W2808066402C2778163477 @default.
• W2808066402 hasConceptScore W2808066402C2778653478 @default.
• W2808066402 hasConceptScore W2808066402C2780026642 @default.

• next